Crossmark

Catgut implantation at acupoints improves anti-PD-1 inhibitor efficacy in lung cancer by inducing immune responses and remodeling the tumor microenvironment

Crossref DOI link: https://doi.org/10.1007/s00262-026-04368-1

Published Online: 2026-03-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Qian

Su, Ting

Zhang, Yuanyuan

Xiong, Yuerong

Hu, Xiaoyan

Shao, Lijuan

Chen, Size
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (32271225)

Key Laboratory for Monitoring Adverse Reactions Associated with CAR-T Cell Therapy (2022ZDB05)

Key Laboratory of Tumor Immunotherapy (2022KSYS002)

Guangdong Engineering and Technology Research Center for Precision Treatment of Esophageal Cancer
License Information

Text and Data Mining valid from 2026-03-31

Version of Record valid from 2026-03-31
More Information

Article History

Received: 30 July 2025

Accepted: 14 March 2026

First Online: 31 March 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below